Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation

The placental inflammatory processes induced maternally result in preterm birth (PTB). Serum amyloid A (SAA) is a well-known biomarker of inflammation. The objective of this study was to investigate whether murine placental SAA isoforms (SAA1–4) participate in the mechanism of spontaneous PTB and wh...

Full description

Bibliographic Details
Main Authors: Yang Liu, Jin Liu, Anguo Liu, Hillary Yin, Irina Burd, Jun Lei
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.902096/full
_version_ 1828235534091157504
author Yang Liu
Yang Liu
Jin Liu
Anguo Liu
Hillary Yin
Irina Burd
Jun Lei
author_facet Yang Liu
Yang Liu
Jin Liu
Anguo Liu
Hillary Yin
Irina Burd
Jun Lei
author_sort Yang Liu
collection DOAJ
description The placental inflammatory processes induced maternally result in preterm birth (PTB). Serum amyloid A (SAA) is a well-known biomarker of inflammation. The objective of this study was to investigate whether murine placental SAA isoforms (SAA1–4) participate in the mechanism of spontaneous PTB and whether maternal regulation of SAA production may serve as a therapeutic approach. During the gestation, all isoforms of SAA were detectable except SAA2. The mouse model of intrauterine inflammation was established using LPS infusion to the uterus. Following intrauterine inflammation, placental SAA2 increased significantly. Inhibition of Saa2, using siSaa2, markedly decreased PTB. The increased placental expression of pro-inflammatory cytokines Il1β, Il6, and Tnfα were downregulated by siSaa2 treatment. Maternal inhibition of Saa2 did not change the expression of Saa1–4 in the fetal brain. Explant inflammatory culture of placentas with siSaa2 showed similar results to our in vivo experiments. This study demonstrates the highly expressed placental SAA2 as a novel therapeutic target, and maternal administration of siRNA as a promising approach to alleviate PTB.
first_indexed 2024-04-12T20:16:50Z
format Article
id doaj.art-286652d296bc406f8859a5213f33dbf4
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T20:16:50Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-286652d296bc406f8859a5213f33dbf42022-12-22T03:18:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.902096902096Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammationYang Liu0Yang Liu1Jin Liu2Anguo Liu3Hillary Yin4Irina Burd5Jun Lei6Integrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha, ChinaIntegrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesIntegrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesIntegrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesIntegrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesIntegrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesThe placental inflammatory processes induced maternally result in preterm birth (PTB). Serum amyloid A (SAA) is a well-known biomarker of inflammation. The objective of this study was to investigate whether murine placental SAA isoforms (SAA1–4) participate in the mechanism of spontaneous PTB and whether maternal regulation of SAA production may serve as a therapeutic approach. During the gestation, all isoforms of SAA were detectable except SAA2. The mouse model of intrauterine inflammation was established using LPS infusion to the uterus. Following intrauterine inflammation, placental SAA2 increased significantly. Inhibition of Saa2, using siSaa2, markedly decreased PTB. The increased placental expression of pro-inflammatory cytokines Il1β, Il6, and Tnfα were downregulated by siSaa2 treatment. Maternal inhibition of Saa2 did not change the expression of Saa1–4 in the fetal brain. Explant inflammatory culture of placentas with siSaa2 showed similar results to our in vivo experiments. This study demonstrates the highly expressed placental SAA2 as a novel therapeutic target, and maternal administration of siRNA as a promising approach to alleviate PTB.https://www.frontiersin.org/articles/10.3389/fimmu.2022.902096/fullpreterm birthintrauterine inflammationserum amyloid A (SAA)placentasiRNA treatment
spellingShingle Yang Liu
Yang Liu
Jin Liu
Anguo Liu
Hillary Yin
Irina Burd
Jun Lei
Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation
Frontiers in Immunology
preterm birth
intrauterine inflammation
serum amyloid A (SAA)
placenta
siRNA treatment
title Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation
title_full Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation
title_fullStr Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation
title_full_unstemmed Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation
title_short Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation
title_sort maternal sirna silencing of placental saa2 mitigates preterm birth following intrauterine inflammation
topic preterm birth
intrauterine inflammation
serum amyloid A (SAA)
placenta
siRNA treatment
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.902096/full
work_keys_str_mv AT yangliu maternalsirnasilencingofplacentalsaa2mitigatespretermbirthfollowingintrauterineinflammation
AT yangliu maternalsirnasilencingofplacentalsaa2mitigatespretermbirthfollowingintrauterineinflammation
AT jinliu maternalsirnasilencingofplacentalsaa2mitigatespretermbirthfollowingintrauterineinflammation
AT anguoliu maternalsirnasilencingofplacentalsaa2mitigatespretermbirthfollowingintrauterineinflammation
AT hillaryyin maternalsirnasilencingofplacentalsaa2mitigatespretermbirthfollowingintrauterineinflammation
AT irinaburd maternalsirnasilencingofplacentalsaa2mitigatespretermbirthfollowingintrauterineinflammation
AT junlei maternalsirnasilencingofplacentalsaa2mitigatespretermbirthfollowingintrauterineinflammation